Screening method

Details Screening method Screening method

2004-09-09

2009-12-01

Cheu, Jacob (Department: 1641)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S007100

Reexamination Certificate

active

07625696

ABSTRACT:
The present invention provides a method of screening an agent for the prevention/treatment of cancer. More specifically, the present invention provides a screening method/screening kit for screening a compound or its salt that changes the binding properties of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or salts thereof, to a ligand capable of binding specifically to the protein, which comprises using (a) the protein, its partial peptides, or salts thereof and (b) the ligand capable of binding specifically to the protein; compounds obtained by the screening or salts thereof; agents for the prevention/treatment of cancer comprising the compounds or salts thereof; and so on.

REFERENCES:
patent: 6555339 (2003-04-01), Liaw et al.
patent: 2001/0016325 (2001-08-01), Mobley et al.
patent: WO 96/24604 (1996-08-01), None
patent: WO 99/64021 (1999-12-01), None
patent: WO 01/39780 (2001-06-01), None
Campbell (section 1.3.4. p. 29; Monoclonal Antibody Technology (1984) Elsevier Science Publishers).
Nanus et al., “Retinoids and Prostate Cancer”, Prostate Journal, vol. 2, No. 2, 2000, pp. 68-73.
Dillard et al., “Retinol inhibits the growth of retinoic acid-resistant colon cancer cells via a retinoic acid-idependent mechanism”, Database Biosis, Database Accession No. PREV200300358460, FASEB Journal, vol. 17, No. 4-5, Mar. 2003.
Murakami et al., “Vitamin A-related compounds, all-transretinal and retinoic acids, selectively inhibit activities of mammalian replicative DN polymerases”, Biochimica et Biophysica Acta, vol. 1574, No. 1, Feb. 20, 2002, pp. 85-92.
Kimura et al., “Orphan G Protein-coupled Receptor, GPR4 1, Induces Apoptosis via a p53/Bas Pathway during Ischmic Hypoxia and Reoxygenation”, Journal of Biological Chemistry, vol. 276, No. 28, Jul. 13, 2001, pp. 26453-26460.
A.N. Fanjul, et al., “4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors,” The Journal of Biological Chemistry, (1996), 271(37): 22441-22446.
T.M. Ahola, et al., “G Protein-Coupled Receptor 30 Is Critical for a Progestin-Induced Growth Inhibition in MCF-7 Breast Cancer Cells”, Endocrinology, (2002), 143(9): 3376-3384.
C. Carmeci, et al., “Identification of a Gene J(GPR30) with Homology to the G-Protein-Coupled Receptor Superfamily Associated with Estrogen Receptor Expression in Breast Cancer”, Genomics, (1997), 45: 607-617.
A. Hanza, et al., “Plausible Interaction of an Alpha-fetoprotein Cyclopeptide with the G-protein-coupled Receptor Model GPR30: Docking Study by Molecular Dynamics Simulated Annealing”, Journal of Biomolecular Structure & Dynamics, (2003), 20(6): 751-758.

Affiliated with

Also associated with

Rating

Screening method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4076135